diaDexus Stock Price, News & Analysis (OTCMKTS:DDXS)

$0.0090 0.00 (0.00 %)
(As of 01/17/2018 11:44 AM ET)
Previous Close$0.01
Today's RangeN/A
52-Week RangeN/A
Volume13 shs
Average Volume12,614 shs
Market Capitalization$36,900.00
P/E Ratio0.00
Dividend YieldN/A
Beta1.67

About diaDexus (OTCMKTS:DDXS)

diaDexus logoDiadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Receive DDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for DDXS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:DDXS
CUSIPN/A
Phone+1-650-2466400

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-0.00452261306532663
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($1.99)
Net IncomeN/A
Net Margins-47.79%
Return on EquityN/A
Return on Assets-58.13%

Miscellaneous

EmployeesN/A
Outstanding Shares4,100,000

diaDexus (OTCMKTS:DDXS) Frequently Asked Questions

What is diaDexus' stock symbol?

diaDexus trades on the OTCMKTS under the ticker symbol "DDXS."

How were diaDexus' earnings last quarter?

diaDexus, Inc. (OTCMKTS:DDXS) issued its earnings results on Monday, October, 26th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.69) by $0.35. View diaDexus' Earnings History.

Who are some of diaDexus' key competitors?

Who are diaDexus' key executives?

diaDexus' management team includes the folowing people:

  • Lori F. Rafield Ph.D., Chairman of the Board, Chief Executive Officer (Age 60)
  • Leone D. Patterson, Chief Financial Officer (Age 54)
  • Emi Zychlinsky Ph.D., Executive Vice President, Chief Technology Officer (Age 59)
  • Christopher P. Lowe, Chief Accounting Officer (Age 46)
  • Jonathan Ruais, Vice President of Marketing
  • Kenneth C. Fang M.D., Chief Medical Officer (Age 53)
  • R. Michael Richey, Chief Business Officer (Age 60)
  • James R. Sulat, Director (Age 66)
  • John T. Curnutte M.D. Ph.D., Independent Director (Age 65)
  • Karen Drexler, Independent Director (Age 55)

How do I buy diaDexus stock?

Shares of diaDexus can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is diaDexus' stock price today?

One share of diaDexus stock can currently be purchased for approximately $0.01.

How big of a company is diaDexus?

diaDexus has a market capitalization of $36,900.00.

How can I contact diaDexus?

diaDexus' mailing address is 349 Oyster Point Blvd, SOUTH SAN FRANCISCO, CA 94080-1947, United States. The company can be reached via phone at +1-650-2466400.


MarketBeat Community Rating for diaDexus (DDXS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  128
MarketBeat's community ratings are surveys of what our community members think about diaDexus and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

diaDexus (OTCMKTS:DDXS) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

diaDexus (OTCMKTS:DDXS) Earnings History and Estimates Chart

Earnings by Quarter for diaDexus (OTCMKTS:DDXS)

diaDexus (OTCMKTS DDXS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2015($0.69)($0.34)ViewN/AView Earnings Details
8/13/2015($0.29)($0.87)ViewN/AView Earnings Details
5/12/2015Q115($0.04)($0.02)$5.23 millionViewN/AView Earnings Details
3/11/2015($0.02)($0.04)ViewN/AView Earnings Details
11/5/2014($0.01)($0.03)ViewN/AView Earnings Details
7/28/2014($0.02)($0.01)ViewN/AView Earnings Details
5/7/2014($0.03)($0.07)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

diaDexus (OTCMKTS:DDXS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for diaDexus (OTCMKTS:DDXS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for diaDexus (OTCMKTS DDXS)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

diaDexus (OTCMKTS DDXS) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

diaDexus (OTCMKTS:DDXS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

diaDexus (OTCMKTS DDXS) Stock Chart for Wednesday, January, 17, 2018

Loading chart…

This page was last updated on 1/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.